Gujarat Kidney and Super Speciality Limited held its 7th Annual General Meeting on September 28, 2026. Shareholders approved financial statements, director appointments, and various regulatory borrowing and investment limits.
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Gujarat Kidney And Superspeciality Limited shareholders approved a special resolution via postal ballot. The resolution authorizes variation in the objects/terms of utilization of IPO proceeds.
Gujarat Kidney and Super Speciality Limited has issued a notice for a postal ballot meeting. Shareholders will vote on varying the objects of IPO proceeds.
Gujarat Kidney and Super Speciality Ltd passed a special resolution to vary IPO proceeds utilization. The resolution received 100% approval with 56,894,699 votes in favour.
Gujarat Kidney And Super Speciality Limited announced the passing of three resolutions via postal ballot with requisite majority. Approved items include interim fund utilisation for healthcare expansion, voluntary revision of financial statements, and the appointment of Mr. Dharmendra Bhaliya as Secretarial Auditor for FY 2025-26. Voting concluded on April 25, 2026, with the Scrutinizer's report confirming the results.